Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
107.00
+0.38 (0.36%)
Jul 1, 2026, 4:00 PM EDT - Market closed
Insmed Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -1,184 | -1,277 | -913.77 | -749.57 | -481.53 | -434.65 |
Depreciation & Amortization | 21.03 | 19.16 | 13.73 | 13.29 | 12.29 | 15.26 |
Stock-Based Compensation | 159.2 | 152.71 | 96.84 | 74.78 | 57.69 | 46.02 |
Other Adjustments | 186.28 | 250.19 | 122.51 | 164.47 | 4.54 | 68.65 |
Change in Receivables | -131.86 | -88.31 | -12.93 | -11.96 | -6.42 | -8.12 |
Changes in Inventories | -32.38 | -31.52 | -17.04 | -13.61 | -1.71 | -17.46 |
Changes in Accounts Payable | 127.69 | 100.07 | 44.59 | 15.16 | 50.01 | -7.58 |
Changes in Other Operating Activities | -41.87 | -60.55 | -17.79 | -28.8 | -35.3 | -25.43 |
Operating Cash Flow | -895.66 | -935.01 | -683.88 | -536.25 | -400.44 | -363.3 |
Capital Expenditures | -25.97 | -32.56 | -21.92 | -13.29 | -9.88 | -7.29 |
Purchases of Investments | -1,462 | -2,092 | -1,577 | -588.73 | -99.71 | -50.29 |
Proceeds from Sale of Investments | 1,653 | 2,090 | 1,016 | 375 | 75 | - |
Payments for Business Acquisitions | - | - | - | - | - | -6.7 |
Other Investing Activities | - | -30 | - | 3.42 | - | - |
Investing Cash Flow | 120.53 | -64.58 | -583.18 | -223.6 | -34.58 | -64.29 |
Long-Term Debt Issued | - | - | - | - | 500 | 575 |
Long-Term Debt Repaid | -4.04 | -4.93 | -2.61 | -1.22 | -0.6 | -238.66 |
Net Long-Term Debt Issued (Repaid) | -4.04 | -4.93 | -2.61 | -1.22 | 499.4 | 336.34 |
Issuance of Common Stock | 547.84 | 959 | 1,197 | 170.87 | 311.66 | 291.92 |
Net Common Stock Issued (Repurchased) | 547.84 | 959 | 1,197 | 170.87 | 311.66 | 291.92 |
Other Financing Activities | - | - | -3.74 | -1.22 | -17.78 | -15.72 |
Financing Cash Flow | 954.59 | 954.07 | 1,341 | 168.44 | 793.27 | 612.55 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.52 | 0.93 | -1.31 | -0.25 | -1 | -0.93 |
Net Cash Flow | 178.94 | -44.59 | 72.66 | -591.66 | 357.25 | 184.03 |
Free Cash Flow | -921.64 | -967.58 | -705.81 | -549.54 | -410.32 | -370.59 |
FCF Margin | -112.45% | -159.55% | -194.06% | -180.05% | -167.23% | -196.64% |
Free Cash Flow Per Share | -4.44 | -4.86 | -4.30 | -3.91 | -3.33 | -3.31 |
Levered Free Cash Flow | -1,139 | -1,287 | -914.83 | -778.04 | 33.28 | -140.8 |
Unlevered Free Cash Flow | -1,109 | -1,257 | -880.27 | -739.31 | -443.23 | -416.07 |